Publication dates

All regions

Colorectal Cancer Industry, October 2014 Market Reports from Top Publishers

You might be interested in: cancer, medical equipment, melanoma, more »


 
1-20 of about 8 700 reports for Colorectal Cancer

Aposense Ltd. (Symbol:APOS) SWOT Analysis, Strategy, Revenues and Profits

Aposense Ltd. (Symbol:APOS) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... Of parkinson's disease. The company's att-11t is a therapeutic compound used in the treatment of metastatic solid tumors such as colorectal cancer, lung cancer and ovarian cancer. It markets products through ...

GeneNews Limited (Symbol:GEN) SWOT Analysis, Strategy, Revenues and Profits

GeneNews Limited (Symbol:GEN) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... And commercializes genomic-based clinical laboratory tests. It develops diagnostic tests such as, colonsentry and sentinelgx. Genenews colonsentry is a blood test for colorectal cancer and sentinelgx is used in whole ...

HealthLinx Limited (Symbol:HTX) SWOT Analysis, Strategy, Revenues and Profits

HealthLinx Limited (Symbol:HTX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... Depletion and recovery technology for serum or plasma and other biological fluids. The company offers products for the treatment of colorectal cancer and prostate cancer. It holds for vascular permeability ...

MOLOGEN AG (Symbol:MGN) SWOT Analysis, Strategy, Revenues and Profits

MOLOGEN AG (Symbol:MGN) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... Products for oncology, which include mgn1703 for the treatment of advanced colorectal cancer, mgn1601 for the treatment of treat advanced kidney cancer and mgn1404 for malignant melanoma; and products ...

Pacific Edge Limited (Symbol:PEB) SWOT Analysis, Strategy, Revenues and Profits

Pacific Edge Limited (Symbol:PEB) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... With stage ii or stage iii colorectal cancer. Its cxbladder is a non-invasive laboratory test for the detection of bladder cancer. The company provides diagnostic service through their facilities in new ...

Chronix Biomedical, Inc. - Product Pipeline Analysis, 2014 Update

Chronix Biomedical, Inc. - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • September 2014
  • by Global Data

... Provides assistance for the development of tests in the areas of breast cancer, prostate cancer, colorectal cancer, brain injuries and concussions, bovine spongiform encephalopathy and chronic fatigue ...

Nuclea Biotechnologies Inc. - Product Pipeline Analysis, 2014 Update

Nuclea Biotechnologies Inc. - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • September 2014
  • by Global Data

... Nov 12, 2013: nuclea biotechnologies receives new patent for use in colorectal cancer 35oct 28, 2013: nuclea biotechnologies will begin manufacturing and marketing the her-2 blood test 35dec 12 ...

Biocartis SA - Product Pipeline Analysis, 2014 Update

Biocartis SA - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • September 2014
  • by Global Data

... Multiplex companion diagnostics test product overview 25msi-biomarker diagnostic test - colorectal cancer 26msi-biomarker diagnostic test - colorectal cancer product overview 26septicyte triage ...

Biosceptre International Limited - Product Pipeline Analysis, 2014 Update

Biosceptre International Limited - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • September 2014
  • by Global Data

... Diagnostic test - product status 11breast cancer ihc diagnostic test - product description 11colorectal cancer ihc diagnostic test - product status 12colorectal cancer ihc diagnostic test ...

Oryzon Genomics S.A. - Product Pipeline Analysis, 2014 Update

Oryzon Genomics S.A. - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • September 2014
  • by Global Data

... S diagnostic products include gynec-dx for endometrial cancer; cxbladder for bladder cancer; and colobraf for colorectal cancer. The company produces nces and monoclonal antibodies for neurogeneration and cancer ...

About 1 400 reports for Colorectal Cancer

Download Unlimited Documents from Trusted Public Sources

Pathology Description in the US

  • Colorectal Cancer Statistics, 2014
  • January 2014
    14 pages
  • Colorectal Canc...  

    Cancer  

  • United States  

    North America  

View report >

3 Companies for Colorectal Cancer

Read our Company Profiles

Eli Lilly and Co.

United States

Johnson and Johnson

United States

Lilly and Co.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.